Showing 1 posts of 16 posts found.
Bristol-Myers Squibb and Pfizer are to submit their new anti-clotting drug for European approval in the first half of next …
NHS England approves delayed-release treatment for rare kidney disease
Product value to pathway impact: What the CVD Modern Service Framework means for pharma
Functional lung imaging offers new possibilities for respiratory care
Five Facts about cardiovascular disease
Data integrity: the keystone for AI adoption, patient safety and organisational reputation